DEWPOINT THERAPEUTICS
Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Its technology uses machine-learning-based image analysis tools for visualizing condensates and offers an engine for genetically linked condensatopathy which is a collection of engineered cell lines with trackable condensates to prevent harmful protein sequestration, helping healthcare providers to have access to new therapies to address unmet needs. The company was founded in 2018 and is headquartered in Boston, Massachusetts.
DEWPOINT THERAPEUTICS
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
2018-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.dewpointx.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
287 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL Pound Sterling Japanese Yen MailChimp SPF
Similar Organizations
Aerovate Therapeutics
Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Intergalactic Therapeutics
Intergalactic Therapeutics is an ATP company, is revolutionizing gene therapies with a novel non-viral platform.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Seismic Therapeutic
Seismic Therapeutic is a biotechnology company advancing machine learning for immunology drug development.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Current Advisors List
Current Employees Featured
Founder
Investors List
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Dewpoint Therapeutics
Mirae Asset Capital
Mirae Asset Capital investment in Series C - Dewpoint Therapeutics
Polaris Partners
Polaris Partners investment in Series C - Dewpoint Therapeutics
General Catalyst
General Catalyst investment in Series C - Dewpoint Therapeutics
Leaps by Bayer
Leaps by Bayer investment in Series C - Dewpoint Therapeutics
Maverick Ventures
Maverick Ventures investment in Series C - Dewpoint Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series C - Dewpoint Therapeutics
NS Investment
NS Investment investment in Series C - Dewpoint Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series C - Dewpoint Therapeutics
3E Bioventures
3E Bioventures investment in Series C - Dewpoint Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-28 | Dewpoint Therapeutics Appoints Lori Escobedo as Chief People Officer |
Official Site Inspections
http://www.dewpointx.com Semrush global rank: 2.13 M Semrush visits lastest month: 9.47 K
- Host name: 169.110.212.35.bc.googleusercontent.com
- IP address: 35.212.110.169
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
